| scholarly article | Q13442814 |
| P356 | DOI | 10.1182/BLOOD.V99.10.3830 |
| P698 | PubMed publication ID | 11986243 |
| P50 | author | Stefan Stevanović | Q86390097 |
| Juergen Loeffler | Q88652700 | ||
| Hans-Georg Rammensee | Q1577018 | ||
| Hermann Einsele | Q1610986 | ||
| P2093 | author name string | Christian Sinzger | |
| Lothar Kanz | |||
| Gerhard Jahn | |||
| Georg Rauser | |||
| Manuela Baur | |||
| Holger Hebart | |||
| Andrea Dobler | |||
| Ulrich Grigoleit | |||
| Senay Daginik | |||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Cytomegalovirus | Q6946 |
| cytotoxicity | Q246181 | ||
| lymphocyte | Q715347 | ||
| flow cytometry | Q1141429 | ||
| P1104 | number of pages | 8 | |
| P304 | page(s) | 3830-3837 | |
| P577 | publication date | 2002-05-01 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Sensitive detection of human cytomegalovirus peptide-specific cytotoxic T-lymphocyte responses by interferon-gamma-enzyme-linked immunospot assay and flow cytometry in healthy individuals and in patients after allogeneic stem cell transplantation | |
| P478 | volume | 99 |
| Q40627421 | A CTL epitope from human cytomegalovirus IE1 defined by combining prediction of HLA binding and proteasomal processing is the target of dominant immune responses in patients after allogeneic stem cell transplantation |
| Q40883276 | A Diverse Repertoire of CD4 T Cells Targets the Immediate-Early 1 Protein of Human Cytomegalovirus. |
| Q43538607 | A similarity in peptide cross-reactivity between alloantigen- and nominal antigen-induced CD8+ T cell responses in vitro |
| Q37489881 | Adoptive T cell immunotherapy for cytomegalovirus |
| Q78471193 | Antigens and immunoevasins: opponents in cytomegalovirus immune surveillance |
| Q40010732 | CD8+ T-cell responses to tumor-associated antigens correlate with superior relapse-free survival after allo-SCT. |
| Q84295171 | Cellular immune parameters associated with spontaneous control of CMV in children who underwent transplantation |
| Q35998792 | Cellular immunotherapy for viral infection after HSC transplantation |
| Q36025790 | Clearance of CMV viremia and survival after double umbilical cord blood transplantation in adults depends on reconstitution of thymopoiesis |
| Q35809452 | Clinical implications of T cell receptor repertoire analysis after allogeneic stem cell transplantation |
| Q47111092 | Comprehensive Analysis of Cytomegalovirus pp65 Antigen-Specific CD8+ T Cell Responses According to Human Leukocyte Antigen Class I Allotypes and Intraindividual Dominance |
| Q39895985 | Cross-presentation of HCMV chimeric protein enables generation and measurement of polyclonal T cells |
| Q35917480 | Cytomegalovirus following stem cell transplantation: from pharmacologic to immunologic therapy |
| Q35922928 | Cytomegalovirus in hematopoietic stem cell transplant recipients |
| Q38763847 | Cytomegalovirus reactivation posthematopoietic stem cell transplantation (HSCT) and type of graft: A step toward rationalizing CMV testing and positively impacting the economics of HSCT in developing countries. |
| Q44758867 | Cytomegalovirus-specific immune recovery following allogeneic HLA-identical sibling transplantation with reduced-intensity preparative regimen |
| Q46390290 | Donor lymphocyte infusion and methotrexate for immune recovery after T-cell depleted haploidentical transplantation. |
| Q41099371 | Early detection of cytomegalovirus-specific cytotoxic T lymphocytes against cytomegalovirus antigenemia in human leukocyte antigen haploidentical hematopoietic stem cell transplantation |
| Q46185506 | Early reconstitution of effector memory CD4+ CMV-specific T cells protects against CMV reactivation following allogeneic SCT. |
| Q47812892 | Early recovery of immunity after cord-blood transplantation in children: qualitative features and impact of cytomegalovirus infection |
| Q36933904 | Expansion of human cytomegalovirus (HCMV) immediate-early 1-specific CD8+ T cells and control of HCMV replication after allogeneic stem cell transplantation |
| Q33198743 | Flow cytometric enumeration of antigen-specific T lymphocytes. |
| Q104100276 | Flow cytometric measurement of STAT5 phosphorylation in CMV stimulated T Cells |
| Q34720787 | Glucocorticosteroids trigger reactivation of human cytomegalovirus from latently infected myeloid cells and increase the risk for HCMV infection in D+R+ liver transplant patients |
| Q92206244 | Identification of HCMV-derived T cell epitopes in seropositive individuals through viral deletion models |
| Q35675862 | Immune reconstitution following haematopoietic stem cell transplantation |
| Q37050965 | Immunobiology of human cytomegalovirus: from bench to bedside. |
| Q39382670 | Immunotherapy for transplantation-associated viral infections |
| Q57209258 | Impact of MHC class I alleles on the M. tuberculosis antigen-specific CD8+ T-cell response in patients with pulmonary tuberculosis |
| Q37024817 | Impairment of cytomegalovirus-specific cellular immune response as a risk factor for cytomegalovirus disease in transplant recipients |
| Q21092179 | Induction of pluripotent protective immunity following immunisation with a chimeric vaccine against human cytomegalovirus |
| Q37081007 | Interplay between human cytomegalovirus and dendritic cells in T cell activation |
| Q43449637 | Isolation and characterization of cynomolgus macaque (Macaca fascicularis) cytomegalovirus (CyCMV). |
| Q45925385 | Lack of prompt expansion of cytomegalovirus pp65 and IE-1-specific IFNgamma CD8+ and CD4+ T cells is associated with rising levels of pp65 antigenemia and DNAemia during pre-emptive therapy in allogeneic hematopoietic stem cell transplant recipients |
| Q33382369 | Levels of CMV specific CD4 T cells are dynamic and correlate with CMV viremia after allogeneic stem cell transplantation |
| Q53898460 | Management of CMV infections: recommendations from the infectious diseases working party of the EBMT. |
| Q44714539 | Management of cytomegalovirus infection in haemopoietic stem cell transplantation |
| Q38822159 | Management of cytomegalovirus infection in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations. |
| Q43155511 | Monitoring cytomegalovirus T-cell immunity in small bowel/multivisceral transplant recipients |
| Q34358755 | Monitoring of human cytomegalovirus and virus-specific T-cell response in young patients receiving allogeneic hematopoietic stem cell transplantation |
| Q42180502 | Persistence of recipient-derived as well as donor-derived clones of cytomegalovirus pp65-specific cytotoxic T cells long after allogeneic hematopoietic stem cell transplantation |
| Q35558815 | Prevention of Cytomegalovirus Disease in Recipients of Allogeneic Stem Cell Transplants |
| Q36403419 | Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells |
| Q58074723 | QuantiFERON®-CMV assay for the assessment of cytomegalovirus cell-mediated immunity |
| Q42276223 | Rapid monitoring of immune reconstitution after allogeneic stem cell transplantation--a comparison of different assays for the detection of cytomegalovirus-specific T cells. |
| Q83225298 | Reconstitution of CMV pp65 and IE-1-specific IFN-γ CD8(+) and CD4(+) T-cell responses affording protection from CMV DNAemia following allogeneic hematopoietic SCT |
| Q81261927 | Reconstitution of HLA-A*2402-restricted cytomegalovirus-specific T-cells following stem cell transplantation |
| Q40809488 | Reconstitution of cytomegalovirus-specific T-cell response in allogeneic hematopoietic stem cell recipients: the contribution of six frequently recognized, virus-encoded ORFs |
| Q47564568 | Relative dominance of HLA-B*07 restricted CD8+ T-lymphocyte immune responses to human cytomegalovirus pp65 in persons sharing HLA-A*02 and HLA-B*07 alleles |
| Q37130450 | STEP trial and HIV-1 vaccines inducing T-cell responses |
| Q35794646 | Separating antiviral and GVHD activities of donor T cells prior to bone marrow transplantation |
| Q42277578 | Single-cell T-cell receptor-β analysis of HLA-A*2402-restricted CMV- pp65-specific cytotoxic T-cells in allogeneic hematopoietic SCT. |
| Q35200641 | Specific infectious complications after stem cell transplantation |
| Q37862743 | Surrogate markers of infection: interrogation of the immune system |
| Q36069582 | Synthetic DNA approach to cytomegalovirus vaccine/immune therapy |
| Q55025898 | The Detailed Kinetics of Cytomegalovirus-specific T cell Responses after Hematopoietic Stem Cell Transplantation: 1 Year Follow-up Data. |
| Q38547042 | The immune response to cytomegalovirus in allogeneic hematopoietic stem cell transplant recipients |
| Q38014916 | Therapeutic strategies for the prevention and treatment of cytomegalovirus infection |
| Q33209970 | Use of peptides and peptide libraries as T-cell stimulants in flow cytometric studies. |
| Q54354990 | Virologic and immunologic monitoring of cytomegalovirus to guide preemptive therapy in solid-organ transplantation. |
Search more.